SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
| pages: 1 2
|
presentations:
1 to
50 of
88
|
DENIAL, DOOM, OR DESTINY? RESURGENT STIS IN HIV CARE AND PREVENTION (ABSTRACT
12)
Jeanne M Marrazzo
University of Alabama, Birmingham, USA
INFLAMMATION: TAMING THE FLAMES (ABSTRACT
13)
Irini Sereti
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
HPV VACCINE WITH LEEP DID NOT PREVENT RECURRENT CERVICAL HSIL IN HIV-INFECTED WOMEN (ABSTRACT
14)
Cindy Firnhaber
University of Colorado Medical Center, Aurora, CO, USA
OPTIMAL LUNG CANCER SCREENING CRITERIA AMONG PERSONS LIVING WITH HIV (ABSTRACT
15)
Subhashini A Sellers
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
HIV IS ASSOCIATED WITH DECREASED BREAST CANCER SURVIVAL: A PROSPECTIVE COHORT STUDY (ABSTRACT
16)
Katrin Sara Sadigh
Brigham and Women's Hospital, Boston, MA, USA
LONG-TERM OUTCOMES OF 58 PATIENTS WITH HIV AND KSHV+ MULTICENTRIC CASTLEMAN DISEASE (ABSTRACT
17)
Ramya Ramaswami
HIV AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
REDUCTION OF KAPOSI SARCOMA–ASSOCIATED HERPESVIRUS LATENCY USING CRISPR-CAS9 (ABSTRACT
18)
For Yue Tso
University of Nebraska - Lincoln, Lincoln, NE, USA
THE ROLE OF WILMS' TUMOR 1 IN KAPOSI SARCOMA HERPESVIRUS ONCOGENESIS (ABSTRACT
19)
Ayana Morales
Weill Cornell Medical College, New York, NY, USA
QUANTIFICATION OF KSHV DNA AS A DIAGNOSTIC TEST FOR KAPOSI SARCOMA IN AFRICA (ABSTRACT
20)
Aggrey Semeere
Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda
TWO NOVEL POTENTIAL THERAPEUTIC TARGETS IN THE KSHV LIFE CYCLE (ABSTRACT
21)
Thomas Schulz
Medizinischen Hochschule Hannover, Hannover, Germany
RANDOMIZED TRIAL OF RALTEGRAVIR-ART VS EFAVIRENZ-ART WHEN INITIATED DURING PREGNANCY (ABSTRACT
39)
Mark Mirochnick
Boston University School of Medicine, Hingham, MA, USA
RCT OF DOLUTEGRAVIR VS EFAVIRENZ-BASED THERAPY INITIATED IN LATE PREGNANCY: DOLPHIN-2 (ABSTRACT
40)
Saye Khoo
University of Liverpool Institute of Translational Medicine, Liverpool, United Kingdom
MATERNAL HBV VIREMIA IS ASSOCIATED WITH ADVERSE INFANT OUTCOMES IN HIV/HBV WOMEN (ABSTRACT
41)
Debika Bhattacharya
University of California Los Angeles, Los Angeles, CA, USA
IMPACT OF IMPROVED NUTRITION/SANITATION ON NEURODEVELOPMENT OF HIV-EXPOSED CHILDREN (ABSTRACT
42)
Robert Ntozini
Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe
UNIQUE IMMUNOLOGICAL AND VIROLOGICAL FEATURES OF EARLY TREATED HIV-INFECTED NEWBORNS (ABSTRACT
43)
Pilar Garcia Broncano
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
NEONATAL ART < 7 DAYS VS 7-28 DAYS REDUCED TIME TO SUPPRESSION (ABSTRACT
44)
Sara Dominguez Rodriguez
Fundación Investigación Biomédica Hospital 12 Octubre, Madrid, Spain
SAFETY AND PHARMACOKINETICS OF MONOCLONAL ANTIBODY, VRC01LS, IN HIV-EXPOSED NEWBORNS (ABSTRACT
45)
Elizabeth J McFarland
University of Colorado School of Medicine, Aurora, CO, USA
BICTEGRAVIR/FTC/TAF SINGLE-TABLET REGIMEN IN ADOLESCENTS & CHILDREN: WEEK 48 RESULTS (ABSTRACT
46)
Aditya Gaur
St. Jude Children's Research Hospital, Memphis, TN, USA
BREAKING BONES IS BAD: INCIDENT FRACTURE AND MORTALITY IN THE HIV OUTPATIENT STUDY (ABSTRACT
30)
Linda Ann Battalora
Colorado School of Mines, Golden, CO, USA
COPD AND THE RISK FOR MYOCARDIAL INFARCTION BY TYPE IN PEOPLE LIVING WITH HIV (ABSTRACT
31)
Kristina Crothers
University of Washington, Seattle, WA, USA
SUDDEN CARDIAC DEATH AMONG HIV-INFECTED AND -UNINFECTED VETERANS (ABSTRACT
32)
Matthew Freiberg
Vanderbilt University School of Medicine, Nashville, TN, USA
HIV POST SCD STUDY: 80% HIGHER RATE OF AUTOPSY-DEFINED SUDDEN ARRHYTHMIC DEATH IN HIV (ABSTRACT
33)
Zian H. Tseng
UCSF, San Francisco, CA, USA
CABOTEGRAVIR IS NOT ASSOCIATED WITH WEIGHT GAIN IN HIV-NEGATIVE INDIVIDUALS: HPTN 077 (ABSTRACT
34)
Raphael J. Landovitz
University of California Los Angeles, Los Angeles, CA, USA
ASSESSING THE PROBIOTIC EFFECT IN TREATED HIV: RESULTS OF ACTG A5350 (ABSTRACT
35)
Edgar Turner Overton
University of Alabama, Birmingham, AL, USA
FACTOR X INHIBITION REDUCES COAGULATION BUT NOT INFLAMMATION IN PERSONS WITH HIV (ABSTRACT
36)
Jason V Baker
Hennepin Healthcare Research Institute (U of MN), Minneapolis, MN, USA
SAFETY, TOLERABILITY AND IMMUNOLOGIC ACTIVITY OF RUXOLITINIB ADDED TO SUPPRESSIVE ART (ABSTRACT
37)
Vincent C. Marconi
School of Medicine, Emory University, Atlanta, GA, USA
INCIDENT SYPHILIS RATES AND PREDICTORS IN US WOMEN WITH HIV, 2005-2016 (ABSTRACT
47)
Jodie Dionne-Odom
University of Alabama at Birmingham, Birmingham, AL, USA
PREPARING FOR PREP IN ENGLAND: PREVALENCE AND INCIDENCE OF HIV AND BACTERIAL STIS (ABSTRACT
48)
Dana Ogaz
Public Health England, London, United Kingdom
EXPANDING TESTING STRATEGIES IN PARIS: A FREE POSTAL COMPREHENSIVE STI TEST KIT (ABSTRACT
49)
Heloise M Delagreverie
Hôpital Saint Louis - APHP, Paris, France
RANDOMIZED CONTROLLED TRIAL OF INTRAUTERINE DEVICE SAFETY IN WOMEN LIVING WITH HIV (ABSTRACT
50)
Catherine S Todd
FHI360, Durham, NC, USA
DOUBLE-DOSE LEVONORGESTREL IMPLANT DOES NOT FULLY OVERCOME INTERACTION WITH EFAVIRENZ (ABSTRACT
51)
Kimberly K. Scarsi
University of Nebraska, Omaha, NE, USA
PHARMACOGENETICS WORSENS AN ADVERSE ANTIRETROVIRAL-HORMONAL CONTRACEPTIVE INTERACTION (ABSTRACT
52)
David Haas
Vanderbilt University School of Medicine, Nashville, TN, USA
POINT-OF-CARE VIRAL LOAD TESTING IMPROVES HIV VIRAL SUPPRESSION AND RETENTION IN CARE (ABSTRACT
53)
Paul K Drain
University of Washington, Seattle, WA, USA
EFFECT OF THE HITS INTERVENTION ON HIV TESTING UPTAKE AMONG MEN IN SOUTH AFRICA (ABSTRACT
54)
Hae-Young Kim
Africa Health Research Institute, Durban, South Africa
TARGETING THE NONCANONICAL NF-ΚB PATHWAY REVERSES SIV LATENCY (ABSTRACT
22)
Maud Mavigner
Emory University School of Medicine, Atlanta, GA, USA
NONSUPPRESSIBLE VIREMIA ON ART FROM LARGE CELL CLONES CARRYING INTACT PROVIRUSES (ABSTRACT
23)
Elias K Halvas
University of Pittsburgh, Pittsburgh, PA, USA
EX VIVO AND IN VIVO EDITING OF THE SIV GENOME IN NONHUMAN PRIMATES BY CRISPR-CAS9 (ABSTRACT
24)
Tricia H. Burdo
Temple University School of Medicine, Philadelphia, PA, USA
DELAYED VIRAL REBOUND DURING ATI AFTER INFUSION OF CCR5 ZFN-TREATED CD4 T CELLS (ABSTRACT
25)
Pablo Tebas
University of Pennsylvania, Philadelphia, PA, USA
MULTIDOSE IV ROMIDEPSIN: NO INCREASED HIV-1 EXPRESSION IN PERSONS ON ART, ACTG A5315 (ABSTRACT
26)
Deborah McMahon
University of Pittsburgh, Pittsburgh, PA, USA
PEMBROLIZUMAB INDUCES HIV LATENCY REVERSAL IN HIV+ INDIVIDUALS ON ART WITH CANCER (ABSTRACT
27)
Thomas S Uldrick
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
POTENT ANTIVIRAL ACTIVITY OF TRISPECIFIC BROADLY NEUTRALIZING HIV ANTIBODIES (ABSTRACT
28)
Amarendra Pegu
Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA
SUSTAINED HIV-1 REMISSION FOLLOWING HOMOZYGOUS CCR5 DELTA32 ALLOGENIC HSCT (ABSTRACT
29)
Ravindra K Gupta
University College London, London, United Kingdom
THEMED DISCUSSION LEADER
Blossom Damania
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
PRIMARY ROLE OF KSHV IN PATHOGENESIS OF ENDEMIC AND EPIDEMIC KAPOSI SARCOMA (ABSTRACT
270)
Salum Juma Lidenge
University of Nebraska-Lincoln, Lincoln, NE, USA
METABOLIC ABNORMALITIES IN CD8 T CELLS FROM HIV+ INDIVIDUALS WITH KAPOSI SARCOMA (ABSTRACT
271)
Genevieve Tyndale Clutton
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
SINGLE CELL EVALUATION OF KAPOSI SARCOMA TUMORS REVEALS COMPLEX IMMUNE INFILTRATE (ABSTRACT
272)
Warren Phipps
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
NEW VARIANT OF KAPOSI SARCOMA–ASSOCIATED HERPESVIRUS IN MEN WHO HAVE SEX WITH MEN (ABSTRACT
273)
Aude Jary
AP–HP, Hôpitaux Universitaires Pitié Salpêtrière, Paris, France
THEMED DISCUSSION LEADER
Rodolphe Garraffo
Université de Nice-Sophia-Antipolis, Hôpital Pasteur, CHU de Nice, Nice, France
PI DRUG-LEVEL TESTING AS A SCREENING TOOL FOR DRUG RESISTANCE IN 2ND-LINE ART FAILURE (ABSTRACT
461)
Lucas Etienne Hermans
University Medical Center Utrecht, Johannesburg, South Africa
|
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
| pages: 1 2
|
presentations:
1 to
50 of
88
|
